Active Pharmaceutical Ingredients
| Product Name | CAS No. | Specification | Application | Registration |
| Linaclotide Acetate | 851199-60-5 | 98+% | ||
| Linaclotide | 851199-59-2 | 98%+ HPLC | ||
| Selexipag (NS-304) | 475086-01-2 | 99+% | ||
| (S)-(+)-Camptothecin (CPT) | 7689-03-4 | 98+% | ADC Cytotoxin inhibitor | Topoisomerase inhibitor | Apoptosis related activator | MicroRNA inhibitor | |
| HCTU | 330645-87-9 | 99+% | ||
| Ibrutinib (PCI-32765) | 936563-96-1 | 98+% | ||
| Orlistat | 96829-58-2 | 98+% | ||
| Schizophyllan | 9050-67-3 | 85+% | Carbohydrates, Nucleosides & Nucleotides | |
| Temsirolimus (CCI-779) | 162635-04-3 | 98+% | mTOR inhibitor | Autophagy activator | Apoptosis related activator | |
| CY5 (Sulfo-Cyanine5) | 146368-11-8 | 98+% | ||
| Dinoprost Tromethamine Salt | 38562-01-5 | 98+% | Prostaglandin Receptor agonist | |
| Dipeptide Diaminobutyroyl Benzylamide Diacetate | 823202-99-9 | 98+% | mAChR antagonist. | |
| Trastuzumab (anti-HER2) | 180288-69-1 | 95+% | EGFR | ADC Antibody |Antineoplastic Agent |the treatment of HER2 receptor positive breast cancer | |
| Cetuximab | 205923-56-4 | 95+% | Antineoplastic Agent | |
| Ercalcitriol (1α,25-Dihydroxyvitamin D2) | 60133-18-8 | 98+% |
Products
- All
- Pharmaceutical Intermediates
- Active Pharmaceutical Ingredients
- Anti-Cancer (Oncology)
- Vitamin D Series Compounds
- Antibody-Drug Conjugates
- Prostaglandins
- Immunosuppressants
- Cardiovascular
- Antiviral Agents
- Anti-Diabetic
- Peptides
- Veterinary
- Antibacterial
- Miscellaneous
- Drug Impurities & Metabolites
- Novel Life Science Reagents
- Amino Acids & Vitamins
- Natural Products
- Health & Nutritional Ingredients
- Pharmaceutical Excipients
- Specialty Chemicals & Building Blocks
Custom Synthesis-High Value-Added Advanced Pharmaceutical Intermediates
E-Mail: sales (at)Chemleader.com.cn
E-Mail: sales (at)Chemleader.com.cn